SLDB (STOCKS)
Solid Biosciences Inc. Common Stock
$6.300000
-0.630000 (-9.09%)
Prev close: $6.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Alexander Gery Cumbo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $529.57M
- Employees
- 100
- P/E (TTM)
- -2.57
- P/B (TTM)
- 2.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.48 | $-0.45 | -0.0325 | -7.26% |
|
Jun 2025 (Q2)
|
$-0.42 | $-0.51 | +0.0942 | +18.32% |
|
Mar 2025 (Q1)
|
$-0.59 | $-0.57 | -0.0231 | -4.07% |
|
Dec 2024 (Q4)
|
$-1.00 | $-0.82 | -0.1777 | -21.61% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $2.56M |
| Operating Expenses | $169.70M |
| Depreciation and Amortization | $1.66M |
| Research and Development | $132.96M |
| Other Operating Expenses | $35.08M |
| Operating Income/Loss | -$169.70M |
| Income/Loss From Continuing Operations After Tax | -$167.14M |
| Income/Loss From Continuing Operations Before Tax | -$167.14M |
| Net Income/Loss | -$167.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$167.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$167.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.48 |
| Diluted Earnings Per Share | -$2.48 |
| Basic Average Shares | 85,703,679 |
| Diluted Average Shares | 85,703,679 |
| Assets | $273.91M |
| Current Assets | $244.85M |
| Cash | $236.10M |
| Other Current Assets | $8.75M |
| Noncurrent Assets | $29.06M |
| Fixed Assets | $4.36M |
| Other Non-current Assets | $24.71M |
| Liabilities | $55.97M |
| Current Liabilities | $36.34M |
| Accounts Payable | $8.43M |
| Other Current Liabilities | $27.91M |
| Noncurrent Liabilities | $19.62M |
| Equity | $217.95M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $217.95M |
| Liabilities And Equity | $273.91M |
| Net Cash Flow From Operating Activities | -$132.38M |
| Net Cash Flow From Operating Activities, Continuing | -$132.38M |
| Net Cash Flow From Investing Activities | -$66.90M |
| Net Cash Flow From Investing Activities, Continuing | -$66.90M |
| Net Cash Flow From Financing Activities | $196.24M |
| Net Cash Flow From Financing Activities, Continuing | $196.24M |
| Net Cash Flow | -$3.04M |
| Net Cash Flow, Continuing | -$3.04M |
| Comprehensive Income/Loss | -$167.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$167.20M |
| Other Comprehensive Income/Loss | -$68.00K |